HOME >> BIOLOGY >> NEWS
Oldest DNA ever recovered suggests earth was warmer than previously believed

A team of international researchers has collected the oldest ever recovered DNA samples and used them to show that Greenland was much warmer at some point during the last Ice Age than most people have believed.

The ancient DNA was discovered at the bottom of a two kilometer thick ice sheet and came from the trees, plants and insects of a boreal forest estimated to be between 450,000 and 900,000 years-old. Previously, the youngest evidence of a boreal forest in Greenland was from 2.4 million years ago.

The results of the research were published today in the journal Science.

"These findings allow us to make a more accurate environmental reconstruction of the time period from which these samples were taken, and what we've learned is that this part of the world was significantly warmer than most people thought," said Martin Sharp, a glaciologist at the University of Alberta and a co-author of the paper.

Sharp said the silty ice found underneath the huge Greenland glacier created a perfect, natural "freezer" to preserve the prehistoric DNA. Scientists have, in the past, found older organic matter, but they have not found any uncontaminated DNA that is as old or older than the Greenland samples.

Sharp and his PhD student Joel Barker contributed to the research by providing DNA samples from the silty ice of much younger glaciers (3,000 years-old) on Ellesmere Island in Arctic Canada. The Canadian DNA samples offered a control sample for the researchers around the world who worked to estimate the age of the Greenland DNA samples.

The work in Canada also contributed to the evidence that suggests the boreal forest DNA samples found in Greenland were from forests that grew where the samples were found and were not from plant matter carried by wind or water from forests elsewhere in the world.

The DNA samples suggest the temperature of the southern Greenland boreal forests 450,000 to 900,000 years-ago wa
'"/>

Contact: Ryan Smith
ryan.smith@ualberta.ca
780-492-0436
University of Alberta
5-Jul-2007


Page: 1 2

Related biology news :

1. Oldest animal fossils may have been bacteria
2. Oldest complex organic molecules found in ancient fossils
3. Oldest juvenile skeleton discovered will help piece together human development
4. Oldest cranial, dental and postcranial fossils of early modern European humans confirmed
5. Oldest fossil human protein ever sequenced
6. New study suggests Concord grape juice may provide protection against breast cancer
7. Study suggests estrogen deficiency can lead to obesity-induced high blood pressure after menopause
8. Experiment suggests limitations to carbon dioxide tree banking
9. Immunity in social amoeba suggests ancient beginnings
10. New model for autism suggests women carry the disorder and explains age as a risk factor
11. Pediatric ritalin use may affect developing brain, new study suggests

Post Your Comments:
(Date:5/7/2015)... , May 7, 2015 ... sensors, FPC1022 and FPC1035, FPC,s smallest touch fingerprint ... are mainly considered for integration on the backside ... smartphone OEMs increased possibilities to integrate touch fingerprint ... size also improves possibilities for module manufacturers to ...
(Date:4/27/2015)... Profile Solutions, Inc. (OTC: PSIQ), a leading ... pleased to announce that Dr Gerry Bedore ... of its scientific advisory board. ... leader in technology-enhanced learning models. He was a co-founder ... studies and books focused on online student success and ...
(Date:4/14/2015)... , April 14, 2015  HYPR Corp. ... Online (FIDO ® ) Alliance tm , an ... FIDO members commit to share technology and collaborate ... that are interoperable, more secure and private, and ... biometric identity verification that protects sensitive user information ...
Breaking Biology News(10 mins):FPC Introduces its Smallest Touch Fingerprint Sensors to Date 2Profile Solutions Names Medicinal Cannabis, Agriculture and Technology Expert Dr. Gerry Bedore to its Scientific Advisory Board 2Profile Solutions Names Medicinal Cannabis, Agriculture and Technology Expert Dr. Gerry Bedore to its Scientific Advisory Board 3Profile Solutions Names Medicinal Cannabis, Agriculture and Technology Expert Dr. Gerry Bedore to its Scientific Advisory Board 4HYPR Corp. Joins the FIDO Alliance 2HYPR Corp. Joins the FIDO Alliance 3
(Date:5/21/2015)... NOVATO, Calif. , May 21, 2015 /PRNewswire-USNewswire/ ... Orrin Hatch (R-UT) and Amy ... Product Extensions Now Accelerating Cures & Treatments, or ... 150 rare disease patient advocacy organizations, this bipartisan ... effective, and affordable medicines to rare disease patients ...
(Date:5/21/2015)... W. R. Grace & Co. ... Worms, Germany has received good manufacturing practice (GMP) ... International Pharmaceutical Excipient Council (IPEC) Foundation. ... SYLOID® FP brand of pharmaceutical grade excipient silica ... Curtis Bay, Maryland (USA) and Sorocaba, Brazil locations. ...
(Date:5/21/2015)... , May 21, 2015  CytRx Corporation (NASDAQ: ... company specializing in oncology, today announced positive updated ... with aldoxorubicin for the treatment of unresectable glioblastoma ...  The open-label, multisite trial is designed to investigate ... patients whose tumors have progressed following prior treatment ...
(Date:5/21/2015)... Research and Markets ( http://www.researchandmarkets.com/research/84975r/2015_global ... "2015 Global Survey on Flow Cytometry Adoption Trends" ... primary goal of this research is to analyze ... Key information the survey seeks to collect include ... predominantly used applications for flow cytometers, respondents, most ...
Breaking Biology Technology:Advocates Cheer Senate Leaders for Introducing Bipartisan Bill to Increase Number of Rare Disease Treatments 2Grace European Facility Receives GMP Excipient Certification for SYLOID® FP Silica Gel 2CytRx Reports Positive Updated Phase 2 Aldoxorubicin Clinical Trial Results in Glioblastoma Multiforme (Brain Cancer) 2CytRx Reports Positive Updated Phase 2 Aldoxorubicin Clinical Trial Results in Glioblastoma Multiforme (Brain Cancer) 3CytRx Reports Positive Updated Phase 2 Aldoxorubicin Clinical Trial Results in Glioblastoma Multiforme (Brain Cancer) 4CytRx Reports Positive Updated Phase 2 Aldoxorubicin Clinical Trial Results in Glioblastoma Multiforme (Brain Cancer) 5CytRx Reports Positive Updated Phase 2 Aldoxorubicin Clinical Trial Results in Glioblastoma Multiforme (Brain Cancer) 6CytRx Reports Positive Updated Phase 2 Aldoxorubicin Clinical Trial Results in Glioblastoma Multiforme (Brain Cancer) 7Global Survey on Flow Cytometry Adoption Trends 2015 2
Cached News: